SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-002765
Filing Date
2024-02-05
Accepted
2024-02-05 21:30:30
Documents
1
Period of Report
2024-02-01

Document Format Files

Seq Description Document Type Size
1 form4-02062024_020218.html 4  
1 form4-02062024_020218.xml 4 4279
  Complete submission text file 0001415889-24-002765.txt   5747
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Issuer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IMMUNOGEN, INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
Kalofonos Isabel (Reporting) CIK: 0001975163 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17999 | Film No.: 24597872